Synthesis and pharmacological characterization of [125I]iodomethyllycaconitine ([125I]iodo-MLA). A new ligand for the α7 nicotinic acetylcholine receptor [2]

Journal of Medicinal Chemistry

Volumn 43, Issue 2, 2000, Pages 142-145

  Navarro, Hernán A ^a   Zhong, Desong ^a   Abraham, Philip ^a   Xu, Heng ^a   Carroll, F Ivy ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODOMETHYLLYCACONITINE I 125; NICOTINIC RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

COGNITION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENTERITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; PARKINSON DISEASE; REACTION ANALYSIS;

ANIMALS; CHOLINERGIC AGENTS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; IODINE RADIOISOTOPES; LIGANDS; RATS; RECEPTORS, NICOTINIC;

EID: 0034719376     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990544f     Document Type: Letter

References (41)

1. Decker, M. W.; Arneric, S. P. Nicotinic acetylcholine receptor-targeted compounds: A summary of the development pipeline and therapeutic potential. In Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities; Arneric, S. P., Brioni, J. D., Eds.; Wiley-Liss: New York, 1999; pp 395-411.
2. Holladay, M. W.; Dart, M. J.; Lynch, J. K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 1997, 40, 4169-4194.
3. Marks, M. J.; Collins, A. C. Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate. Mol. Pharmacol. 1982, 22, 554-564.
4. Lindstrom, J.; Schoepfer, R.; Conroy, W. G.; Whiting, P. Structural and functional heterogeneity of nicotinic receptors. Ciba Found. Symp. 1990, 152, 23-52.
5. Lindstrom, J. Purification and cloning of nicotinic acetylcholine receptors. In Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities; Arneric, S. P., Brioni, J. D., Eds.; Wiley-Liss: New York, 1999; pp 3-23.
6. 125I] α-bungarotoxin. J. Neurosci. 1985, 5, 1307-1315.
7. Seguela, P.; Wadiche, J.; Dineleymiller, K.; Dani, J. A.; Patrick, J. W. Molecular cloning, functional properties, and distribution of rat brain-alpha7 - a nicotinic cation channel highly permeable to calcium. J. Neurosci. 1993, 13, 596-604.
8. Marks, M. J.; Stitzel, J. A.; Romm, E.; Wehner, J. M.; Collins, A. C. Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine, and a-bungarotoxin. Mol. Pharmacol. 1986, 30, 427-436.
9. Villemagne, V. L.; Musachio, J. L.; Scheffel, U. Nicotine and related compounds as PET and SPECT ligands. In Neuronal. Nicotinic Receptors: Pharmacology and Therapeutic Opportunities; Arneric, S. P., Brioni, J. D., Eds.; Wiley-Liss: New York, 1999; pp 235-250.
10. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol. Pharmacol. 1995, 48, 280-287.
11. 125I]IPH, an epibatidine analogue, binds with high affinity to neuronal nicotinic cholinergic receptors. J. Pharmacol. Exp. Ther. 1997, 282, 445-451.
12. 123/126I]iodo-3-(2(S)-azetidinylmethoxy)-pyridine: A radioligand for nicotinic acetylcholine receptors. Nucl. Med. Biol. 1999, 26, 175-182.
13. Musachio, J. L.; Villemagne, V. L.; Scheffel, U.; Stathis, M.; Finley, P.; Horti, A.; London, E. D.; Dannals, R. F. [125/123I]-IPH: a radioiodinated analogue of epibatidine for in vivo studies of nicotinic acetylcholine receptors. Synapse 1997, 26, 392-399.
14. 125/123I]lodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analogue of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. Life Sci. 1998, 62, PL 351-357.
15. Scheffel, U.; Taylor, G. F.; Kepler, J. A.; Carroll, F. I.; Kuhar, M. J. In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidine. NeuroReport 1995, 6, 2483-2488.
16. Ding, Y.-S.; Gatley, S. J.; Fowler, J. S.; Volkow, N. D.; Aggarwal, D.; Logan, J.; Dewey, S. L.; Liang, F.; Carroll, F. I.; Kuhar, M. J. Mapping nicotinic acetylcholine receptors with PET. Synapse 1996, 24, 403-407.
17. Ding, Y.-S.; Gatley, S. J.; Fowler, J. S.; Volkow, N. D.; Aggarwal, D.; Logan, J.; Dewey, S. L.; Liang, F.; Carroll, F. I.; Kuhar, M. J. Mapping nicotinic acetylcholine receptors with PET. Society for Neuroscience, Washington, DC, 1996; Abstract 22, p 269.
18. 18F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane.
19. 18F]N-methyl-NFEP: Kinetics, nicotine effect, and toxicity. Nucl. Med. Biol. 1999, 26, 139-148.
20. 18F]fluoronorchloroepibatidine in rodent and human brain. Nucl. Med. Biol. 1998, 25, 449-454.
21. 18F]norchlorofluoroepibatidine and its N-methyl derivative: New PET ligands for mapping nicotinic acetylcholine receptors. J. Labelled Compd. Radiopharm. 1997, 39, 827-832.
22. Liang, F.; Navarro, H. A.; Abraham, P.; Kotian, P.; Ding, Y.-S.; Fowler, J.; Volkow, N.; Kuhar, M. J.; Carroll, F. I. Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2′-fluoro-5′-pyridinyl)-7-azabicyclo[2.2.1]heptane: A new positron emission tomography ligand for nicotinic receptors. J. Med. Chem. 1997, 40, 2293-2295.
23. Loc'h, C.; Kassiou, M.; Musachio, J. L.; Coulon, C.; Ottaviani, M.; Bottlaender, M.; London, e.d.; Dannals, R. F.; Maziere, B. [Br-76]-BrPH: A radiobrominated analogue of epibatidine for studies of nicotinic acetylcholine receptors using PET. XIIth International Symposium on Radiopharmaceutical Chemistry, Upsala, Sweden. J. Labelled Compd. Radiopharm. 1997, 40, 519-521.
24. Patt, J. T.; Spang, J. E.; Westera, G.; Buck, A.; Schubiger, P. A. Synthesis and in vivo studies of [C-11]N-methylepibatidine: Comparison of the stereoisomers. Nucl. Med. Biol. 1999, 26, 165-173.
25. Dolle, F.; Dolci, L.; Valette, H.; Hinnen, F.; Vaufrey, F.; Guenther, I.; Fuseau, C.; Coulon, C.; Bottlaender, M.; Crouzel, C. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emission tomography ligand for nicotinic receptors. J. Med. Chem. 1999, 42, 2251-2259.
26. Dolci, L.; Dolle, F.; Valette, H.; Vaufrey, F.; Fuseau, C.; Bottlaender, M.; Crouzel, C. Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging. Bioorg. Med. Chem. 1999, 7, 467-479.
27. 18F]A-85380). J. Labelled Compd. Radiopharm. 1998, 47, 309-318.
28. 11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors. J. Med. Chem. 1998, 41, 4199-4206.
29. 18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl. Med. Biol. 1998, 25, 599-603.
30. Mebs, D.; Narita, K.; Iwanaga, S.; Samejima, Y.; Lee, C. Y. Amino acid sequence of a-bungarotoxin from the venom of Bungarus multicinctus. Biochem. Biophys. Res. Commun. 1971, 44, 711-716.
31. Turek, J.; Kang, C.; Campbell, J.; Arneric, S.; Sullivan, J. A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist methyllycaconitine, in rat plasma and brain. J. Neurosci. Methods 1995, 61, 113-118.
32. Pelletier, S. W.; Ross, S. A.; Kulanthaivel, P. New alkaloids from Delphinium elatum L. Tetrahedron 1989, 45, 1887-1892.
33. Pelletier, S. W.; Sawhney, R. S.; Desai, H. K.; Mody, N. V. The diterpenoid alkaloids of Consolida ambigua. J. Nat. Prod. 1980, 43, 395-406.
34. 3H]methyllycaconitine: A new radioligand for labeling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 1999, 38, 679-690.
35. Macallan, D. R. E.; Lunt, G. G.; Wonnacott, S.; Swanson, K. L.; Rapoport, H.; Albuquerque, E. X. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett. 1988, 226, 357-363.
36. Alkondon, M.; Pereira, E. F. R.; Wonnacott, S.; Albuquerque, E. X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol 1992, 41, 802-808.
37. Wonnacott, S.; Albuquerque, E. X.; Bertrand, D. Methyllycaconitine: A new probe that discriminates between nicotinic acetylcholine receptor subclasses. In Methods in Neurosciences; Academic Press, Inc.: New York, 1993; Vol. 12, pp 263-275.
38. Holladay, M. W.; Cosford, N. D. P.; McDonald, I. A. Natural products as a source of nicotinic acetylcholine receptor modulators and leads for drug discovery. In Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities; Arneric, S. P., Brioni, J. D., Eds.; Wiley-Liss: New York, 1999; pp 253-270.
39. Ward, J. M.; Cockcroft, V. B.; Lunt, G. G.; Smillie, F. S.; Wonnacott, S. Methyllycaconitine; A selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 1990, 270, 45-48.
40. Meyer, E. M.; Tay, E. T.; Zoltewicz, J. A.; Meyers, C.; King, M. A.; Papke, R. L.; De Fiebre, C. M. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties. J. Pharmacol. Exp. Ther. 1998, 284, 1026-1032.
41. Brioni, J. D.; Decker, M. W.; Sullivan, J. P.; Arneric, S. P. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv. Pharmacol. 1997, 37, 1153-1214.